Washington, DC
Marissa Hill Daley advises private equity investors, pharmaceutical and medical device manufacturers, and other life sciences industry clients on a wide range of regulatory, compliance, and transactional matters related to the oversight of the US Food and Drug Administration (FDA). She provides regulatory counsel on issues involving risk management, product development, marketing approval, and promotional compliance matters. Marissa also advises clients through internal and government investigations, including defending clients against whistleblower qui tam suits under the False Claims Act. Marissa regularly advises on matters in connection with capital markets, financing, and M&A transactions involving FDA-regulated entities, including on cross-border transactions.
- LMG Life Sciences Americas Awards, Shortlisted for US Rising Star – Regulatory, 2025
- Volunteer Legal Advocates, Volunteer of the Year, 2024
- District of Columbia Courts, Capital Pro Bono High Honor Roll, 2023, 2024
- Inspector General’s Cooperative Achievement Award, 2022, 2023
- Office of Inspector General Office of Counsel Award for Exemplary Work, 2021, 2022, 2023
- Office of Inspector General Office of Counsel Award for Innovation, 2021
- Georgetown University Law Center, adjunct professor of law
- Volunteer Legal Advocates, junior board member, volunteer
- American University Washington College of Law, JD
- Villanova University, BA
- District of Columbia
Insights, News & Events
